Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISEREDE FYSIOTERAPEUTER ÅBOULEVARDEN 70 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.8% 0.7% 0.8% 0.9% 0.9% 0.9% 6.5% 6.2%   Credit score (0-100)   92 94 91 87 90 87 36 38   Credit rating   AA AA AA A A A BBB BBB   Credit limit (kDKK)   201.3 204.9 285.3 206.6 274.5 155.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,659 2,150 2,771 2,782 3,693 3,118 0.0 0.0   EBITDA   1,725 1,379 2,106 1,782 2,086 1,645 0.0 0.0   EBIT   1,279 940 1,661 1,332 1,626 1,205 0.0 0.0   Pre-tax profit (PTP)   1,229.8 891.3 1,623.7 1,313.0 1,623.3 1,182.5 0.0 0.0   Net earnings   956.1 693.7 1,263.7 1,030.1 1,265.9 920.9 0.0 0.0   Pre-tax profit without non-rec. items   1,230 891 1,624 1,313 1,623 1,183 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   333 327 266 406 329 271 0.0 0.0   Shareholders equity total   1,356 1,450 2,114 1,944 2,010 1,059 33.8 33.8   Interest-bearing liabilities   1,156 1,006 0.0 0.1 0.0 266 1,402 1,402   Balance sheet total (assets)   4,050 3,872 3,557 3,091 3,336 2,656 1,435 1,435   Net Debt   1,125 958 -334 -90.9 -361 236 1,402 1,402     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,659 2,150 2,771 2,782 3,693 3,118 0.0 0.0   Gross profit growth   27.2% -19.1% 28.9% 0.4% 32.7% -15.6% -100.0% 0.0%   Employees   3 2 2 3 4 3 0 0   Employee growth %   50.0% -33.3% 0.0% 50.0% 33.3% -25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,050 3,872 3,557 3,091 3,336 2,656 1,435 1,435   Balance sheet change%   -22.4% -4.4% -8.1% -13.1% 7.9% -20.4% -46.0% 0.0%   Added value   1,725.1 1,379.1 2,105.9 1,782.0 2,076.0 1,644.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -893 -828 -889 -693 -920 -880 -271 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   48.1% 43.7% 60.0% 47.9% 44.0% 38.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.6% 23.7% 44.7% 40.1% 50.6% 40.2% 0.0% 0.0%   ROI %   33.5% 28.9% 55.2% 49.9% 65.2% 58.5% 0.0% 0.0%   ROE %   45.5% 49.4% 70.9% 50.8% 64.0% 60.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   33.5% 37.4% 59.4% 62.9% 60.2% 39.9% 2.4% 2.4%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   65.2% 69.5% -15.8% -5.1% -17.3% 14.3% 0.0% 0.0%   Gearing %   85.2% 69.4% 0.0% 0.0% 0.0% 25.1% 4,141.8% 4,141.8%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 4.5% 7.5% 31,648.3% 4,663.3% 16.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.8 0.7 1.2 0.7 0.0 0.0   Current Ratio   0.2 0.3 0.9 0.8 1.3 0.7 0.0 0.0   Cash and cash equivalent   30.6 47.9 333.6 91.0 360.6 30.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,581.3 -1,121.0 -87.0 -107.2 255.2 -344.6 -700.8 -700.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   575 690 1,053 594 519 548 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   575 690 1,053 594 521 548 0 0   EBIT / employee   426 470 831 444 407 402 0 0   Net earnings / employee   319 347 632 343 316 307 0 0